All News
Study: CKD Not Worsened With Gout Treatment
(MedPage Today) -- Worries that urate-lowering therapy (ULT) could speed renal failure in patients with gout and chronic kidney disease (CKD) are unfounded, data from Great Britain indicated.
Read MoreDicen que los esfuerzos contra el fraude en ACA han dado resultados. Pero hay que estar alerta
Los Centros de Servicios de Medicare y Medicaid atribuyen esta reducción a las medidas adoptadas para prevenir problemas de inscripción y cambios de planes, que ya habían generado más de 274,000 q
Read MoreAbout 20 terminally ill people in UK die in unrelieved pain each day, research finds
Office of Health Economics says it also found one in four receiving palliative care in England have ‘unmet pain needs’An estimated 20 terminally ill people in the UK die in unrelieved pain each da
Read MoreSTAT+: Cassava Sciences and its Alzheimer’s drug are done. The damage lingers
The Cassava Sciences story ended Monday exactly as many knew it would — with the company’s experimental drug for Alzheimer’s disease, simufilam, failing a clinical trial.
Read MoreTrump nominates three key leaders in health care
Late Friday evening, President-elect Donald Trump announced a slew of intended nominations for his administration, including three key leaders in health care. Here's what you need to know.
Read MoreAutopsy Data Reveal New Insights About Brain Swelling After Pediatric TBI
(MedPage Today) -- Bilateral brain swelling was more common in children than in adults who died after moderate or severe traumatic brain injury (TBI), an autopsy case series showed.
Read MoreSTAT+: Minnesota becomes first state to release report on 340B drug discount program for ‘safety-net’ hospitals
Minnesota has becomes the first state to release a report examining the 340B drug discount program for "safety-net" hospitals.
Read MoreBarzolvolimab Shows Promise for Cold Urticaria and Dermographism
(MedPage Today) -- The investigational monoclonal antibody barzolvolimab significantly improved provocation test outcomes and reduced symptoms compared with placebo in patients with cold urticaria an
Read MorePhilly's Tax on Sugary Drinks Did Not Trim Kids' Obesity
(MedPage Today) -- Philadelphia's beverage tax on sugary drinks was not associated with changes in pediatric weight outcomes 2 years after it took effect, researchers found.
Read MoreAcoramidis Snags FDA Approval for ATTR Cardiomyopathy
(MedPage Today) -- Acoramidis (Attruby) gained FDA approval for treating wild-type or variant transthyretin (TTR) amyloidosis cardiomyopathy (ATTR-CM), BridgeBio Pharma announced.
Read More